Demographic and Clinical Characteristics of Chronic Myeloid Leukemia Patients: A Study on Confined Populations of Southern India

Author:

Gorre Manjula1,Sashidhar RB1,Annamaneni Sandhya2,Digumarti Raghunadharao3,Satti Vishnupriya2

Affiliation:

1. Departments of Biochemistry, University College of Science, Osmania University, Hyderabad, Telangana, India

2. Departments of Genetics, University College of Science, Osmania University, Hyderabad, Telangana, India

3. Departments of Department of Medical Oncology, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India

Abstract

Abstract Context: Chronic myeloid leukemia (CML) is one of the most common hematological malignancies in all populations throughout the world. Even though the pathophysiology of CML was well explained in majority of the studies, the incidence of CML was shown to exhibit population diversity, and hence, the demographic factors underlying CML origin remain to be understood. Further, the introduction of tyrosine kinase inhibitors had revolutionized the treatment of CML over the years; however, there is a need for developing tailoring therapy to individual risk since the patient clinical heterogeneity poses a major problem during drug response. Therefore, the study of basic clinical picture may aid in planning treatment strategies for CML patients. Aim: The aim of this article is to study the epidemiological and clinical variables associated with the prognosis of CML. Subjects and Methods: We have considered the distribution of various demographic and clinical variables among 476 CML patients diagnosed at Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India. Statistical Analysis Used: All the analyses were performed through SPSS software (version 21.0). Correlation and Cox regression analyses were also performed. Results: Apart from the elevated male sex ratio in CML incidence, high frequency of males was observed to be nonresponders to imatinib mesylate (IM). IM response was shown to be dependent on phase of diagnosis, whereas overall survival of CML patients depends on the age at onset and response to IM. Conclusions: The study of epidemiology and clinical picture of CML patients may help in planning better treatment strategies at diagnosis to achieve long-term progression-free survival.

Publisher

Georg Thieme Verlag KG

Subject

Oncology,Pediatrics, Perinatology, and Child Health

Reference24 articles.

1. Epidemiology of chronic myeloid leukaemia (CML);M Rohrbacher;Best Pract Res Clin Haematol,2009

2. Modern therapy of chronic myeloid leukemia: An example for paradigma shift in hemato-oncology;A A Leitner;Internist (Berl),2011

3. Prognostic discrimination in “good-risk” chronic granulocytic leukemia;J E Sokal;Blood,1984

4. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon Alfa. Writing committee for the Collaborative CML prognostic factors project group;J Hasford;J Natl Cancer Inst,1998

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3